Sales de-grew by 11.9%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
Hikal Share Price
Hikal Share Price
Hikal share price insights
Stock gave a 3 year return of -46.3% as compared to Nifty Smallcap 100 which gave a return of 84.96%. (as of last trading session)
Company has spent 3.16% of its operating revenues towards interest expenses and 13.81% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock generated -46.3% return as compared to Nifty Pharma which gave investors 60.05% return over 3 year time period. (as of last trading session)
Hikal Ltd. share price moved up by 2.54% from its previous close of Rs 329.15. Hikal Ltd. stock last traded price is 337.50
Share Price Value Today/Current/Last 337.50 Previous Day 329.15
Key Metrics
PE Ratio (x) | 64.29 | ||||||||||
EPS - TTM (₹) | 5.50 | ||||||||||
MCap (₹ Cr.) | 4,161.40 | ||||||||||
Sectoral MCap Rank | 52 | ||||||||||
PB Ratio (x) | 3.50 | ||||||||||
Div Yield (%) | 0.34 | ||||||||||
Face Value (₹) | 2.00 | ||||||||||
Beta Beta
| 0.42 | ||||||||||
VWAP (₹) | 352.45 | ||||||||||
52W H/L (₹) |
Hikal Ltd Share Price Returns
1 Day | 4.75% |
1 Week | 7.51% |
1 Month | 12.45% |
3 Months | 25.47% |
1 Year | 14.66% |
3 Years | -43.75% |
5 Years | 141.21% |
Hikal News & Analysis
NewsReliance Chemotex among 9 stocks to trade ex-dividend tomorrow; last chance for eligibility
NewsHolding company stocks rally up to 20%. Here’s why
NewsSpecial call auctions to aid holding companies price discovery, narrow discounts
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcements
Hikal Share Recommendations
Recent Recos
Current
Mean Recos by 1 Analysts
SellSellHoldBuyStrong
Buy
That's all for Hikal recommendations. Check out other stock recos.
Analyst Trends
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 |
Buy | - | - | - | - |
Hold | - | - | - | - |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 1 | 1 | 1 | 1 |
Hikal Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Topline Contraction
Sales de-grew by 11.9%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 3.16% of its operating revenues towards interest expenses and 13.81% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 407.30 514.56 447.63 435.87 388.99 Total Income Growth (%) -20.84 14.95 2.70 12.05 -28.71 Total Expenses 380.60 451.98 411.78 405.93 365.49 Total Expenses Growth (%) -15.79 9.76 1.44 11.06 -24.50 EBIT 26.70 62.58 35.85 29.94 23.50 EBIT Growth (%) -57.33 74.56 19.74 27.40 -61.83 Profit after Tax (PAT) 5.10 33.97 16.14 12.57 6.92 PAT Growth (%) -84.99 110.47 28.40 81.65 -80.78 EBIT Margin (%) 6.56 12.16 8.01 6.87 6.04 Net Profit Margin (%) 1.25 6.60 3.61 2.88 1.78 Basic EPS (₹) 0.41 2.76 1.31 1.02 0.56 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 2,487.15 2,385.48 2,213.11 1,913.22 1,767.98 Total Assets Growth (%) 4.26 7.79 15.67 8.21 4.89 Total Liabilities 1,299.49 1,252.01 1,145.13 979.82 951.48 Total Liabilities Growth (%) 3.79 9.33 16.87 2.98 2.39 Total Equity 1,187.66 1,133.47 1,067.98 933.40 816.50 Total Equity Growth (%) 4.78 6.13 14.42 14.32 7.97 Current Ratio (x) 1.28 1.42 1.25 1.34 1.30 Total Debt to Equity (x) 0.69 0.66 0.63 0.55 0.69 Contingent Liabilities 322.13 225.15 148.28 145.60 111.76 All figures in Rs Cr, unless mentioned otherwise
Insights
Decrease in Cash from Investing
Company has used Rs 173.75 cr for investing activities which is an YoY decrease of 40.57%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 186.72 315.31 293.73 229.02 284.93 Net Cash used in Investing Activities -173.75 -292.34 -284.37 -156.20 -163.80 Net Cash flow from Financing Activities -27.00 -7.68 -5.56 -96.87 -100.86 Net Cash Flow -14.03 15.29 3.80 -24.05 20.27 Closing Cash & Cash Equivalent 12.70 26.73 11.44 7.64 31.68 Closing Cash & Cash Equivalent Growth (%) -52.48 133.63 49.81 -75.90 177.60 Total Debt/ CFO (x) 4.36 2.37 2.30 2.25 1.97 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 5.86 6.91 15.02 14.26 10.34 Return on Capital Employed (%) 8.77 8.90 17.29 19.31 16.59 Return on Assets (%) 2.79 3.28 7.25 6.95 4.77 Interest Coverage Ratio (x) 4.78 5.46 11.07 6.70 3.71 Asset Turnover Ratio (x) 0.73 0.88 0.94 89.92 85.25 Price to Earnings (x) 46.95 44.44 30.96 13.30 10.22 Price to Book (x) 2.75 3.07 4.65 1.90 1.06 EV/EBITDA (x) 15.06 15.87 16.17 6.85 4.91 EBITDA Margin (%) 15.10 12.97 17.78 19.05 18.36
Hikal Ltd Peer Comparison
Hikal Ltd Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -46.3% as compared to Nifty Smallcap 100 which gave a return of 84.96%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -46.3% return as compared to Nifty Pharma which gave investors 60.05% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -46.3% as compared to Nifty Smallcap 100 which gave a return of 84.96%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -46.3% return as compared to Nifty Pharma which gave investors 60.05% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
119.23
Amount Invested (in Cr.)
1.41%
% of AUM
0.00
% Change (MoM basis)
Motilal Oswal Nifty Microcap 250 Index Direct-G
Equity: Small Cap
2.47
Amount Invested (in Cr.)
0.18%
% of AUM
6.88
% Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
0.02
Amount Invested (in Cr.)
0.12%
% of AUM
-8.66
% Change (MoM basis)
MF Ownership as on 31 July 2024
Corporate Actions
Hikal Board Meeting/AGM
Hikal Dividends
- Others
Meeting Date Announced on Purpose Details Aug 01, 2024 Jul 22, 2024 Board Meeting Quarterly Results May 09, 2024 May 02, 2024 Board Meeting Audited Results & Final Dividend Mar 22, 2024 Feb 19, 2024 POM - Feb 08, 2024 Feb 01, 2024 Board Meeting Quarterly Results & Interim Dividend Dec 26, 2023 Nov 24, 2023 POM - Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 30% 0.6 Sep 04, 2024 May 09, 2024 Interim 30% 0.6 Feb 20, 2024 Feb 08, 2024 Final 30% 0.6 Sep 18, 2023 May 29, 2023 Interim 30% 0.6 Feb 14, 2023 Feb 02, 2023 Final 20% 0.4 Sep 14, 2022 May 30, 2022 All Types Ex-Date Record Date Announced on Details Bonus Jun 22, 2018 Jun 25, 2018 May 09, 2018 Bonus Ratio: 1 share(s) for every 2 shares held Splits Feb 27, 2015 Mar 02, 2015 Dec 17, 2014 Split: Old FV10.0| New FV:2.0 Bonus Sep 29, 2003 Oct 01, 2003 Jul 14, 2003 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Aug 23, 2000 - May 13, 2000 Bonus Ratio: 1 share(s) for every 1 shares held
About Hikal
Hikal Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 4,161.40 Crore) operating in Pharmaceuticals sector. Hikal Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024. Show More
Executives
Auditors
- JH
Jai Hiremath
Executive ChairmanSHSameer Hiremath
Managing DirectorSSSarangan Suresh
Whole Time DirectorAKAmit Kalyani
Non Executive DirectorShow More - S R B C & Co. LLPB S R & Co. LLP
Industry
Key Indices Listed on
BSE SmallCap, BSE Healthcare, BSE AllCap, + 3 more
Address
717/718, Maker Chambers V,Nariman Point,Mumbai, Maharashtra - 400021
More Details
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.